For all its success across a wide range of cancer types, Merck’s PD-1 superstar Keytruda has never been able to crack the code for one of the toughest-to-treat indications in oncology—ovarian cancer.

Targeting massive AI clusters, Cisco unveiled the 102.4 Tbps G300 chip along with G300-powered switches designed for hyperscalers, neoclouds, sovereign clouds, service providers, and enterprises.

New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

U.S. Marines prepare to board an MV-22B Osprey at Marine Corps Base Camp Pendleton, California, Sept. 17, 2025. (Cpl. Avery Wayland/U.S. Marine Corps) In the austere desert or island outpost of the ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Sonos represents the high-end tier of wireless audio ...

Editor's Note: This is an excerpt from WBUR's daily morning newsletter, WBUR Today. If you like what you read and want it in your inbox, sign up here. It's Friday. The MBTA is taking the Green Line's ...

Researchers built a chip-sized processor and 3D-printed copper antenna arrays that could enable flexible, wearable wireless systems for auto, aviation, and space. (Nanowerk News) Washington State ...

Enfortumab vedotin and pembrolizumab combination achieved a 39% objective response rate in PD-L1 positive recurrent/metastatic HNSCC patients. Disease control rate was 75.6%, with responses observed ...